Xeris Biopharma Holdings Inc (NASDAQ:XERS) currently has a daily average trading volume of 3.15M but it saw 2373846 shares traded in last market. With a market cap of 787.96M USD, the company’s current market price of $4.92 came falling about -3.15 while comparing to the previous closing price of $5.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.07 and as low as $1.86.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Sandler which downgraded the stock as “Neutral” in its note to investors issued on November 11, 2024, recommending a price target of $3 for it. Craig Hallum issued its recommendations for the stock as it initiated the price target for the stock is $4.50.
Over the week, XERS’s stock price is moving 6.03% up while it is 20.00% when we observe its performance for the past one month. Year-to-date it is 45.13% up and over the past year, the stock is showing an upside performance of 148.48%.
Currently, Xeris Biopharma Holdings Inc’s total number of outstanding shares is 156.01M with 4.00% of that held by the insiders while 54.34% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -20.91% and return on equity (ROE) at -617.16%. It has a 41.58 of forward P/E ratio. Stock’s beta reads 0.70. Stock has a price to sale or P/S ratio amounts to 3.54. Its return on asset (ROA) is -13.83% on average.
